A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC in September, 2018 for $295,974.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC in September, 2019 for $654,778.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC in January, 2021 for $999,863.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC in September, 2016 for $224,520.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC in September, 2017 for $1,453,514.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC in March, 2013 for $2,400,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC in July, 2017 for $1,492,337.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC in July, 2014 for $1,479,785.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC in August, 2015 for $1,444,171.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC in July, 2016 for $223,804.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC for $1,354,170.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC for $2,072,780.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC for $201,931.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC for $224,727.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC for $2,817,320.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC for $2,400,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC for $992,798.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC for $174,984.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC for $1,294,350.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC for $848,082.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC for $194,797.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC for $869,554.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Infinite Biomedical Technologies, LLC for $377,919.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Infinite Biomedical Technologies, LLC for $1,167,800.0 USD from the U.S. Department of Health & Human Services.